Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>

Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air<sup>®</sup> (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air<sup>®</sup> in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Allergy
Published
2024-09-01
DOI
https://doi.org/10.1002/clt2.12390
Citations
4
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
1.53

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®

Nicolás Roche, Piotr Kuna, Bolesław Samoliński, Torsten Zuberbier et al.
4 citations
Clinical and Translational Allergy
Allergic Rhinitis and Sensitization
1.53
article

Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®

Nicolás Roche, Piotr Kuna, Bolesław Samoliński, Torsten Zuberbier, Bilun Gemicioğlu, Marek Kulus, Ilgım Vardaloğlu, Philip W. Rouadi, Benoît Pétré, Tari Haahtela, Mário Morais‐Almeida, Florence Schleich, Markus W. Ollert, Michael P. Makris, Santiago Quirce, Ignacio Javier Ansotegui, Fulvio Braido, Bernardo Sousa‐Pinto, Lorenzo Cecchi, Juan Carlos Ivancevich, Oliver Pfaar, Nikolaos Papadopoulos, Marek Niedoszytko, Désirée Larenas‐Linnemann, Francesca Puggioni, Vincenzo Patella, Luís Taborda‐Barata, Violeta Kvedarienė, Arzu Yorgancıoğlu, Alessandro Fiocchi, Maciej Kupczyk, Álvaro Augusto Cruz, Josep M. Antó, Jean Bousquet, Gilles Louis, Frederico S. Regateiro, Ken Ohta, Maria Teresa Ventura, João Fonseca, J. Sastre, Cláudia Chaves Loureiro, Anna Bedbrook, Philippe Devillier, Sanna Toppila‐Salmi, Arunas Valiulis, Nicola Scichilone, Karl-C Bergmann, Ludger Klimek, Luisa Brussino, Renaud Louis
article en
4 citations

Abstract

Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air<sup>®</sup> (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air<sup>®</sup> in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

Clinical and Translational AllergyVol. 14(9)
Universidade Federal da Bahia (BR), Fundação de Amparo à Pesquisa do Estado da Bahia (BR), University of Helsinki (FI), Humanitas University (IT), University of Liège (BE), Philipps University of Marburg (DE), University of Beira Interior (PT), Manisa Celal Bayar University (TR), Universitat Pompeu Fabra (ES), Vilnius University (LT), University of Eastern Finland (FI), Universidade do Porto (PT), Johannes Gutenberg University Mainz (DE), National and Kapodistrian University of Athens (GR), Université Paris Cité (FR), Medical University of Warsaw (PL), Université Paris-Saclay (FR), Santa Maria Nuova Hospital (IT), Rafik Hariri University Hospital (LB), Helsinki University Hospital (FI), Instituto de Salud Carlos III (ES), Odense University Hospital (DK), Hospitais da Universidade de Coimbra (PT), Hospital Center of Cova da Beira (PT), Humboldt-Universität zu Berlin (DE), Hôpital Cochin (FR), Luxembourg Institute of Health (LU), Hospital Médica Sur (MX), Hospital La Paz Institute for Health Research (ES), Fraunhofer Institute for Translational Medicine and Pharmacology (DE), Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE), Istanbul University-Cerrahpaşa (TR), CUF Porto Hospital (PT), Hospital Quirónsalud Barcelona (ES), Zentrum für Rhinologie und Allergologie (DE), Medical University of Lodz (PL), Bambino Gesù Children's Hospital (IT), A. O. Ordine Mauriziano di Torino (IT), Hospital Universitario Fundación Jiménez Díaz (ES), Institute of Sciences of Food Production (IT), Centre Hospitalier Universitaire de Liège (BE), Institut Hospitalier Franco Britannique (FR), Centre for Health Technology and Services Research (PT), Institut Cochin (FR), Ospedale Policlinico San Martino (IT), Barcelona Institute for Global Health (ES), Fukujuji Hospital (JP), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), National Research Council (IT), Tokyo National Hospital (JP), Azienda Usl Toscana Centro (IT), Hôpital Foch (FR), University of Turin (IT), University of Bari Aldo Moro (IT), Universidad Autónoma de Madrid (ES), University of Naples Federico II (IT), Gdańsk Medical University (PL), Freie Universität Berlin (DE), University of Coimbra (PT), Charité - Universitätsmedizin Berlin (DE), University of Genoa (IT), University of Palermo (IT)
American Heart Association, Mylan, European Commission, Horizon 2020 Framework Programme, HORIZON EUROPE Framework Programme, EIT Health
Openalex Percentile: Top 17%
Allergic Rhinitis and Sensitization
1.53
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.